Abstract
Objectives To develop and implement a ‘Low Dose, High Frequency’ (LDHF) advanced respiratory care training program for COVID-19 care in Lesotho.
Design Prospective pre-post training evaluation.
Setting Lesotho has limited capacity in advanced respiratory care.
Participants Physicians and nurses.
Interventions Due to limited participation May-September 2020 the LDHF approach was modified into a traditional one-day offsite training November 2020 that reviewed respiratory anatomy and physiology, clinical principles for conventional oxygen, heated high flow nasal cannula, and non-invasive ventilation management. Basic mechanical ventilation principles were introduced.
Outcome measures Participants completed a twenty-question multiple choice examination immediately before and after the one-day training. Paired t-tests were used to evaluate the difference in average participant pre- and post-training examination scores.
Results Pre- and post-training examinations were completed by 46/53 (86.7%) participants, of whom 93.4% (n=43) were nurses. The overall mean pre-training score was 44.8% (standard deviation [SD], 12.4.%). Mean scores improved by an average of 23.7 percentage points (95% confidence interval [CI] 19.7, 27.6 percentage points, p<0.001) on the post-training examination to a mean score of 68.5% (SD, 13.6%). Performance on basic and advanced respiratory categories also improved by 17.7 (95% CI: 11.6, 23.8) and 25.6 percentage points (95% CI: 20.4, 30.8) (p<0.001). Likewise, mean examination scores increased on the post-training test, compared to pre-training, for questions related to respiratory management (29.6 percentage points (95% CI: 24.1, 35.0) and physiology (17.4 percentage points (95% CI: 12.0, 22.8).
Conclusions A LDHF training approach was not feasible during this relatively early period of the COVID-19 pandemic in Lesotho. Despite clear knowledge gains the modest post-training examination scores coupled with limited physician engagement suggest healthcare workers require alternative educational strategies before higher advanced care like mechanical ventilation is implementable. Conventional and high flow oxygen are better aligned with post-training healthcare worker knowledge levels and rapid implementation.
Strengths and limitations of this study
The training aimed to use a ‘Low Dose, High Frequency’ approach to improve the competence of doctors and nurses providing advanced respiratory care to severely ill COVID-19 patients during an emergency, pandemic African context with limited advanced respiratory care services.
To provide a foundation for future implementation of invasive mechanical ventilation and more immediate application of conventional oxygen, heated high flow nasal cannula, and non-invasive ventilation, the training coupled pragmatic respiratory anatomy and physiology concepts to key clinical principles.
Challenges in trainee participation and respiratory equipment availability necessitated modifications to the planned ‘Low Dose, High Frequency’ training strategy that reduced both the training duration and approach.
This evaluation provides key lessons for future COVID-19 advanced respiratory care training approaches and the respiratory modalities best aligned with current healthcare worker expertise in Lesotho and likely other similar settings.
Competing Interest Statement
EDM declares other grants from The Bill & Melinda Gates Foundation, National Institutes of Health, Pfizer, The Save the Children Fund (UK), and United States Centers for Disease Control; EDM declares consulting fees from Aurum Institute and unpaid committee participation with the Lifebox Foundation (UK) and World Health Organization. The other authors declare no competing interests.
Funding Statement
This report was made possible with support from the United States Agency for International Development funded RISE program, under the terms of the cooperative agreement 7200AA19CA00003. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Johns Hopkins University Institutional Review Board (IRB00279223) and Lesotho National Health Research Ethics Committee (ID 12-2021) approved this research.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
